Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Tuberculosis D014376 20 associated lipids
Sarcoma 180 D012510 21 associated lipids
Anemia D000740 21 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Li Y et al. Interaction of cortactin and Arp2/3 complex is required for sphingosine-1-phosphate-induced endothelial cell remodeling. 2004 Exp. Cell Res. pmid:15242766
Takeya H ['Vegetable wasps and plant worms' and G-protein-coupled receptors]. 2004 J. UOEH pmid:15244075
Maupas-Schwalm F et al. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. 2004 FASEB J. pmid:15231724
Fujita T et al. Delta-catenin/NPRAP (neural plakophilin-related armadillo repeat protein) interacts with and activates sphingosine kinase 1. 2004 Biochem. J. pmid:15193146
Brinkmann V et al. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. 2004 Am. J. Transplant. pmid:15196057
Im DS et al. Enhancement of sphingosine 1-phosphate-induced phospholipase C activation during G(0)-G(1) transition in rat hepatocytes. 2004 J. Pharmacol. Sci. pmid:15215654
Barnes PJ Ceramide lances the lungs. 2004 Nat. Med. pmid:14760419
Meacci E et al. Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblasts. 2004 Biochem. J. pmid:15109308
Lim HS et al. Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors. 2004 Bioorg. Med. Chem. Lett. pmid:15109640
Cui J et al. Role of ceramide in ischemic preconditioning. 2004 J. Am. Coll. Surg. pmid:15110811
Jolly PS et al. Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. 2004 J. Exp. Med. pmid:15067032
Segura BJ et al. Sphingosine-1-phosphate mediates calcium signaling in guinea pig enteroglial cells. 2004 J. Surg. Res. pmid:14732348
Sanna MG et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. 2004 J. Biol. Chem. pmid:14732717
Forrest M et al. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. 2004 J. Pharmacol. Exp. Ther. pmid:14747617
Yue J et al. Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate level. 2004 Cell. Signal. pmid:14687668
Harada J et al. Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. 2004 J. Neurochem. pmid:14756825
Matloubian M et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. 2004 Nature pmid:14737169
Monick MM et al. Sphingosine kinase mediates activation of extracellular signal-related kinase and Akt by respiratory syncytial virus. 2004 Am. J. Respir. Cell Mol. Biol. pmid:14742298
Kim DS et al. Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. 2004 Cell. Signal. pmid:14607279
Usui S et al. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5. 2004 J. Biol. Chem. pmid:14711826
Gräler MH and Goetzl EJ The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. 2004 FASEB J. pmid:14715694
Ohmori T et al. Platelet-derived sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. 2004 J. Thromb. Haemost. pmid:14717991
Shimamura K et al. Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells. 2004 Eur. J. Pharmacol. pmid:14975703
Anliker B and Chun J Cell surface receptors in lysophospholipid signaling. 2004 Semin. Cell Dev. Biol. pmid:15271291
Tokumura A Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators. 2004 J. Cell. Biochem. pmid:15258912
Muehlich S et al. Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. 2004 Atherosclerosis pmid:15262182
Kohno T and Igarashi Y Roles for N-glycosylation in the dynamics of Edg-1/S1P1 in sphingosine 1-phosphate-stimulated cells. 2004 Glycoconj. J. pmid:15750791
Linz-McGillem LA et al. Cytoskeletal rearrangement and caspase activation in sphingosine 1-phosphate-induced lung capillary tube formation. 2004 Stem Cells Dev. pmid:15588507
Barber SC et al. S1P and LPA trigger Schwann cell actin changes and migration. 2004 Eur. J. Neurosci. pmid:15217370
Levkau B et al. High-density lipoprotein stimulates myocardial perfusion in vivo. 2004 Circulation pmid:15545521
Hale JJ et al. A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists. 2004 J. Med. Chem. pmid:15615513
Lee C et al. Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition. 2004 J Trauma pmid:15580017
Yatomi Y et al. Sphingosine 1-phosphate breakdown in platelets. 2004 J. Biochem. pmid:15625319
Langlois S et al. Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. 2004 Blood pmid:15070679
Ochi S et al. Clostridium perfringens alpha-toxin activates the sphingomyelin metabolism system in sheep erythrocytes. 2004 J. Biol. Chem. pmid:14702348
Hammer S et al. Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation. 2004 J. Cell. Biochem. pmid:14991774
Tokuda H et al. Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts. 2004 J. Cell. Biochem. pmid:15034939
Goetzl EJ and Gräler MH Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes. 2004 J. Leukoc. Biol. pmid:14982946
Fukuda Y et al. Identification of PECAM-1 association with sphingosine kinase 1 and its regulation by agonist-induced phosphorylation. 2004 Biochim. Biophys. Acta pmid:14984734
Tanimoto T et al. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. 2004 Circ. Res. pmid:15044318
vom Dorp F et al. Inhibition of phospholipase C-epsilon by Gi-coupled receptors. 2004 Cell. Signal. pmid:15157671
Lockman K et al. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. 2004 J. Biol. Chem. pmid:15292266
Wang FX et al. mitochondrial ceramidase overexpression up-regulates Bcl-2 protein level in K562 cells, probably through its metabolite sphingosine-1-phosphate. 2004 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15498114
Nakamura H et al. Effects of synthetic sphingosine-1-phosphate analogs on arachidonic acid metabolism and cell death. 2004 Biochem. Pharmacol. pmid:15498509
Billich A and Ettmayer P Fluorescence-based assay of sphingosine kinases. 2004 Anal. Biochem. pmid:14769343
Amano S et al. Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. 2004 Br. J. Dermatol. pmid:15541073
Nosi D et al. Effects of S1P on myoblastic cell contraction: possible involvement of Ca-independent mechanisms. 2004 Cells Tissues Organs (Print) pmid:15655330
Ozbay T et al. ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism. 2004 Endocr. Res. pmid:15666826
Mo FM et al. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. 2004 Eur. J. Pharmacol. pmid:15063151
Elices MJ Editorial overview: Tie me up, tie me down: immunosuppressive therapies for the 21st century. 2004 Curr Opin Investig Drugs pmid:15573862
Otala M et al. Protection from radiation-induced male germ cell loss by sphingosine-1-phosphate. 2004 Biol. Reprod. pmid:14613902
Kelley GG et al. Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins. 2004 Biochem. J. pmid:14567755
Yu N et al. Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes. 2004 Glia pmid:14648542
Formigli L et al. Sphingosine 1-phosphate induces cell contraction via calcium-independent/Rho-dependent pathways in undifferentiated skeletal muscle cells. 2004 J. Cell. Physiol. pmid:14584038
Argraves KM et al. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. 2004 J. Biol. Chem. pmid:15377653
Grey A et al. Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate. 2004 Calcif. Tissue Int. pmid:15354862
Clemens JJ et al. Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists. 2004 Bioorg. Med. Chem. Lett. pmid:15341948
Gonzalez E et al. Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. 2004 J. Biol. Chem. pmid:15292187
Lee H et al. Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism. 2004 Am. J. Physiol., Cell Physiol. pmid:15294853
Matsushita K et al. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15273282
Augé N et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. 2004 Circulation pmid:15277330
Chavakis T et al. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. 2004 FASEB J. pmid:15208269
Xu CB et al. Sphingosine signaling and atherogenesis. 2004 Acta Pharmacol. Sin. pmid:15210056
Yokoo E et al. Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells. 2004 J. Biochem. pmid:15213242
Pierre SC et al. PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate. 2004 EMBO J. pmid:15257286
McVerry BJ and Garcia JG Endothelial cell barrier regulation by sphingosine 1-phosphate. 2004 J. Cell. Biochem. pmid:15258893
Karliner JS Mechanisms of cardioprotection by lysophospholipids. 2004 J. Cell. Biochem. pmid:15258895
Goetzl EJ et al. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. 2004 J. Cell. Biochem. pmid:15258896
Le Stunff H et al. Generation and metabolism of bioactive sphingosine-1-phosphate. 2004 J. Cell. Biochem. pmid:15258913
Duan HF et al. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. 2004 Exp. Cell Res. pmid:15265705
Melendez AJ and Ibrahim FB Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptor-dependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis. 2004 J. Immunol. pmid:15265887
Deretic D et al. Phosphoinositides, ezrin/moesin, and rac1 regulate fusion of rhodopsin transport carriers in retinal photoreceptors. 2004 Mol. Biol. Cell pmid:13679519
Ikeda H et al. Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation. 2004 Biochem. Biophys. Res. Commun. pmid:15240112
Misasi R et al. Prosaposin: a new player in cell death prevention of U937 monocytic cells. 2004 Exp. Cell Res. pmid:15242760
Waeber C et al. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. 2004 Jul-Aug Drug News Perspect. pmid:15334188
Perez GI et al. A central role for ceramide in the age-related acceleration of apoptosis in the female germline. 2005 FASEB J. pmid:15728664
Lindner K et al. Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. 2005 Br. J. Pharmacol. pmid:15735657
Ikeda M et al. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme. 2005 Biochem. Biophys. Res. Commun. pmid:15737611
Yabu T et al. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. 2005 Blood pmid:15741222
Vessey DA et al. A rapid radioassay for sphingosine kinase. 2005 Anal. Biochem. pmid:15649386
Saini HS et al. Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. 2005 J. Neurochem. pmid:16313513
Mizugishi K et al. Essential role for sphingosine kinases in neural and vascular development. 2005 Mol. Cell. Biol. pmid:16314531
Shida D et al. Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells. 2005 Biochem. Biophys. Res. Commun. pmid:15649431
Armulik A et al. Endothelial/pericyte interactions. 2005 Circ. Res. pmid:16166562
Itagaki K et al. Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. 2005 J. Leukoc. Biol. pmid:15522918
Formigli L et al. Sphingosine 1-phosphate induces cytoskeletal reorganization in C2C12 myoblasts: physiological relevance for stress fibres in the modulation of ion current through stretch-activated channels. 2005 J. Cell. Sci. pmid:15728255
Inagaki Y et al. Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors. 2005 Biochem. J. pmid:15733055
Ohmori T et al. The intracellular action of sphingosine 1-phosphate in GPVI-mediated Ca2+ mobilization in platelets. 2005 Thromb. Res. pmid:15733975
Murakami T et al. Synthesis and biological properties of novel sphingosine derivatives. 2005 Bioorg. Med. Chem. Lett. pmid:15686924
Edsbagge J et al. Vascular function and sphingosine-1-phosphate regulate development of the dorsal pancreatic mesenchyme. 2005 Development pmid:15689381
Jaillard C et al. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. 2005 J. Neurosci. pmid:15703400
Geoffroy K et al. Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. 2005 FEBS Lett. pmid:15710421
Budnik LT and Brunswig-Spickenheier B Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor. 2005 J. Lipid Res. pmid:15716590
Duan HF et al. [Establishment of a method for determining the sphingosine kinase activity and its initial application]. 2005 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21180179
Yin Z and Watsky MA Chloride channel activity in human lung fibroblasts and myofibroblasts. 2005 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:15681397
Radeke HH et al. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. 2005 J. Immunol. pmid:15728487
Segura BJ et al. Sphingosine-1-phosphate induces early response gene expression in C6 glioma cells. 2005 Brain Res. Mol. Brain Res. pmid:15710251
Zaslavsky A et al. Sphingosine-1-phosphate induces a PDGFR-dependent cell detachment via inhibiting beta1 integrin in HEK293 cells. 2005 FEBS Lett. pmid:15987639
Chae SS and Hla T Inhibition of gene expression in vivo using multiplex siRNA. 2005 Methods Mol. Biol. pmid:15990401
Berdyshev EV et al. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15766719